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Summary
The bio-economy is in transit from innovation to
commercialization. The bioprocess industry is
expected to increasingly deliver bio-products to the
market, in large amounts, at high quality and at com-
petitive cost levels. This requires ﬂawless start-up
of new large-scale bioprocesses and continuous
improvement of running processes. Fermentation
scale-up and operation can beneﬁt from recent
advances in three areas: 1. computation-driven
design of scale-down simulators, 2. omics-driven
metabolic engineering and 3. sensing and under-
standing of population heterogeneity. Integration of
these ﬁelds requires a uniﬁed computational
approach, linked to big data and simulated reality
frameworks, of which the contours are becoming
visible today.
Introduction
Today, scale-up in the fermentation industry is still driven
by physical guidelines (Delvigne et al., 2006) or heuristic
approaches but does not consider individual cellular
properties for ab initio and in silico design (Takors,
2012), nor high-resolution data on ﬂuid dynamics.
Pioneering studies were performed by Lapin et al.
(2006) but could not exploit the full predictive potential
because details of metabolic and transcriptional regula-
tory responses were not yet known and computational
capacities limiting. There thus remains an urgent need to
pass the old scale-up hurdles by the concerted applica-
tion of modern systems and synthetic biology.
In a recent study, Takors and co-workers described
the applications of omics-based diagnostics to biopro-
cess scale-up (Simen et al., 2017). A two-compartment
scale-down reactor (SDR), able to mimic glucose and
ammonia ﬂuctuations typically encountered in large-scale
bioreactors, has been used in order to investigate the
transcriptional response of E. coli. The authors demon-
strated that on the short term, the ppGpp-dependent
stringent response was induced when cells travelled the
heterogeneous section of the SDR. On the long term,
RNAseq analyses showed that around 400 genes were
repeatedly switched on and off when crossing the two
compartments of the SDR. This response induced an
increased ATP demand of 15%. The analysis showed
potential target genes associated with increased ATP
demand for metabolic engineering. Such approach was
previously used by the same research team for re-
designing an E. coli strain with increased glucose uptake
capacity to cope with nutrient-limiting conditions typically
found in industrial fed-batch bioprocess (Michalowski
et al., 2017).
These new ﬁndings point out that predicting microbial
physiological responses to environmental ﬂuctuations
remains a challenge but also that there are vast potential
applications. This then is a good opportunity for present-
ing a modernized version of the scale-down approach,
i.e. an outlook on the different items that have to be con-
sidered for a better understanding of bioprocess scale-
up and the behaviour of cell populations under industrial
process-related conditions (Fig. 1).
The bioprocess industry more than ever needs new, efﬁ-
cient and sustainable routes to manufacture bio-products.
Bioprocesses use the power and versatility of nature via
microorganisms that make the bio-products from renewable
feedstocks. These microorganisms today can be exten-
sively re-programmed into efﬁcient cell factories. However,
the gap between the cell environment at lab-scale – where
the engineering is performed – and production scale is still
causing gross feedstock and asset utilization inefﬁciencies
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and is a barrier to fast and successful scale-up. This bottle-
neck has become one of the most prominent risks for the
bio-economy, which is in transition from innovation (sup-
ported by the revolutions in metabolic engineering and
molecular biology) to commercialization. Development and
application of computational approaches to design better
scale-down simulators are expected to enable faster scale-
up and improve the energy and resource efﬁciency of biore-
ﬁneries, which will accelerate the penetration of bio-innova-
tions to the markets. This bio-based drive is essential to
help solving the mega-issues of climate change, food secu-
rity and energy supply. The integrated computational solu-
tion proposed will further contribute to reconciliation of two
main, competing, business success factors: speed and
quality (Noorman and Heijnen, 2017).
In recent years, signiﬁcant advances have been made
at the level of the following three aspects:
iScale-down simulators like stirred tank/plug ﬂow reactor
set-ups or devices for metabolic stimulation of the cells
are already established and ready-to-use (Neubauer
and Junne, 2010). Additionally, profound know-how for
performing computational ﬂuid and reaction dynamics
(CFD-CRD) is provided linking hydrodynamics with cel-
lular activities (Euler–Lagrange models) to simulate the
impact of large-scale heterogeneities (Delafosse et al.,
2015; Haringa et al., 2017). Against this background,
lifelines of cells in large-scale fermenters can be repro-
duced to investigate their short- and long-term interac-
tions under real production conditions.
iiThe recent application of comprehensive scale-down
studies unravelled the massive metabolic and
transcriptional response of cells in large-scale bioreac-
tors (Lofﬂer et al., 2016; Simen et al., 2017). Such data
provide a fruitful ground for uncovering key regulation
phenomena and translating them in condensed models
which can be used to predict and improve scale-up per-
formance. Additionally, metabolic engineering targets
can be derived by identifying dominant transcriptional
changes as a guideline for smart genome reduction.
iiiSmart synthetic bio-sensors have been developed to
link native regulatory responses with online detectable
signals – or, even smarter – with fermentation control
to screen and select for robust populations of choice.
Such advances allows considering cell-to-cell hetero-
geneity among a population cultivated in large-scale
bioreactors (Delvigne et al., 2014).
All these aspects need to be linked in a uniﬁed compu-
tational approach for highest resolution and precision.
From the computational approach to the much more pow-
erful virtual reality and augmented reality solutions is only
a small step and will further assist to overcome the chal-
lenges of the bioprocess industry. This step is actually
rendered technically well-feasible due to the recent
advances made in big data analysis (i.e. cognitive soft-
ware, machine learning and artiﬁcial intelligence that can




Fig. 1. Overview of the scientiﬁc topics that have to be integrated in modern scale-down studies and more generally for a better understanding
of the impact of environmental ﬂuctuations on microbial cell physiology in large bioreactors.
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